| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.79▲ | 1.79▲ | 1.82▼ | 1.74▲ | 1.71▲ |
| MA10 | 1.79▲ | 1.79▲ | 1.78▲ | 1.67▲ | 1.87▼ |
| MA20 | 1.82▼ | 1.82▼ | 1.77▲ | 1.75▲ | 1.94▼ |
| MA50 | 1.73▲ | 1.70▲ | 1.73▲ | 1.92▼ | 1.87▼ |
| MA100 | 1.72▲ | 1.76▲ | 1.79▲ | 1.97▼ | 2.29▼ |
| MA200 | 1.79▲ | 1.95▼ | 1.99▼ | 1.87▼ | 2.20▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.008▼ | 0.001▲ | 0.023▲ | -0.044▼ |
| RSI | 50.935▲ | 51.646▲ | 51.946▲ | 52.275▲ | 48.484▼ |
| STOCH | 40.296 | 42.068 | 45.004 | 54.382 | 15.354▼ |
| WILL %R | -52.542 | -60.000 | -60.000 | -26.029 | -71.505 |
| CCI | 50.600 | 8.900 | -16.729 | 75.224 | -78.807 |
|
Thursday, November 13, 2025 08:44 AM
Sino-American antibody company Adagene and Third Arc Bio today announced a licensing agreement under which Third Arc Bio will utilize Adagene’s SAFEbody technology platform to generate masked CD3 T ...
|
|
Thursday, November 13, 2025 04:02 AM
SAN DIEGO and SUZHOU, China and SPRING HOUSE, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) and Third Arc Bio, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.88 | 1.90 | 1.80 | 1.83 | 31,113 |
| 13/11/25 | 1.92 | 1.96 | 1.74 | 1.80 | 68,359 |
| 12/11/25 | 1.66 | 1.78 | 1.66 | 1.77 | 26,101 |
| 11/11/25 | 1.67 | 2.0165 | 1.653 | 1.70 | 315,568 |
| 10/11/25 | 1.44 | 1.90 | 1.44 | 1.58 | 332,360 |
| 07/11/25 | 1.59 | 1.70 | 1.30 | 1.405 | 98,397 |
| 06/11/25 | 1.51 | 1.74 | 1.51 | 1.61 | 45,269 |
| 05/11/25 | 1.67 | 1.68 | 1.45 | 1.50 | 147,500 |
| 04/11/25 | 1.71 | 1.78 | 1.6348 | 1.70 | 99,411 |
| 03/11/25 | 1.73 | 1.80 | 1.70 | 1.79 | 40,216 |
|
|
||||
|
|
||||
|
|